Our molecular docking analysis predicted that GBM-N019 interacts with STAT3, CDK6, and mTOR by several hydrogen bonding, alkyl interactions, hydrophobic contacts, and Van der Waal forces created on its backbone with respective amino acid residues of the receptor-binding cavity. The gene discussed is CDK6; the disease is glioblastoma.